EATRIS ERIC

Their core work

EATRIS ERIC is a European Research Infrastructure Consortium that bridges the gap between laboratory discoveries and clinical application in medicine. Based in Amsterdam, they operate a distributed infrastructure across Europe that helps researchers validate biomarkers, access advanced omics technologies, and design better clinical trials. Their core business is making translational research faster and more efficient — ensuring that promising scientific findings actually reach patients. They play a particularly strong role in data management, FAIR data principles, and the ethical-legal-social dimensions (ELSI) of health research.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2018), EATRIS focused on building and professionalizing research infrastructure itself — training infrastructure managers (RItrain), coordinating life-science services (CORBEL), and establishing data management practices. From 2019 onward, their focus shifted decisively toward applied health challenges: personalised medicine, rare diseases, neurodegenerative disorders, and clinical trial platforms, while simultaneously deepening their engagement with EOSC and FAIR data ecosystems. The evolution shows a maturing organization that moved from "building the infrastructure" to "deploying it on real health problems."

EATRIS is moving toward becoming Europe's go-to infrastructure for health data governance and personalised medicine, with increasing focus on neurodegenerative and rare diseases.

How they like to work

EATRIS operates almost exclusively as a participant (19 of 20 projects), which is typical for an infrastructure ERIC — they provide services and expertise to consortia rather than leading research agendas. With 449 unique partners across 42 countries, they function as a major networking hub in European health research. Their participation in both large-scale infrastructure projects (EOSC-Life, CORBEL) and disease-specific consortia (RECOGNISED, EPND) makes them a versatile partner who brings infrastructure capability to any health-focused consortium.

EATRIS has built one of the broadest collaborative networks in European health research, working with 449 distinct partners across 42 countries. Their reach extends well beyond the EU through infrastructure cooperation projects like RI-VIS, which explicitly targets third-country partnerships.

What sets them apart

EATRIS occupies a rare position as both a research infrastructure and an active contributor to disease-specific research. Unlike most ERICs that stay within infrastructure coordination, EATRIS embeds itself in clinical and translational projects where it brings governance expertise, data management capability, and access to distributed facilities. For consortium builders, they offer a single entry point to translational research capacity across Europe — plus credibility with funders as an established ERIC with a strong ELSI and FAIR data track record.

Highlights from their portfolio

• EOSC-Life
  Their largest single grant (EUR 1.69M), building the open collaborative digital space for biological and medical research across Europe's life-science infrastructures.
• EATRIS-Plus
  Their only coordinated project — a strategic effort to consolidate EATRIS capacity in personalised medicine, biomarker validation, and public-private collaboration.
• EJP RD
  Second-largest funding (EUR 940K) in a flagship European Joint Programme tackling rare diseases through shared data, omics access, and training.